organic compounds
The molecular structure of the title compound, C9H16O4, is described by a trans-planar configuration of the propyl chains. The molecule has an approximate pseudo-twofold rotation axis in the crystal structure. The molecules are interconnected by strong O—HO hydrogen bonds and form an R22(8) ring structure.
organic compounds
The title compound, C8H10N3S+·Cl-·H2O, is extensively used as a spectrophotometric reagent for the determination of pharmaceutical compounds, vitamins and environmental samples.
organic compounds
Valdecoxib, C16H14N2O3S, is a non-steroidal anti-inflammatory drug containing a planar isoxazole heterocycle which is substituted at the C atoms with two aromatic rings and a methyl group. In addition to one molecule of valdecoxib, there is half a molecule of ethyl methyl ketone in the asymmetric unit of the title compound [systematic name: 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide ethyl methyl ketone hemisolvate], viz. C16H14N2O3S·0.5C4H8O. The crystal packing is stabilized by N—HO hydrogen bonds. Apart from the orientation of the sulfonamide group, the conformation of the title compound agrees well with that of the recently published orthorhombic polymorph which does not contain any solvent.
organic compounds
The title compound, C10H8N2O4S, serves as a starting material for the synthesis of antihyperglycemic pharmaceuticals. The nearly planar thiazolidine-2,4-dione ring is almost perpendicular to the nitrophenyl ring.
organic compounds
The title compound, C8H7NO2, serves as an intermediate for the synthesis of citalopram. The packing of the planar molecules is stabilized by N—HO and N—HN hydrogen bonds.
organic compounds
The title compound, C8H5BrO2, serves as a starting material for the synthesis of citalopram. It crystallizes with two almost identical molecules in the asymmetric unit.
organic compounds
Supramolecular assembly of the title compound, C12H14ClFN2O, is primarily governed by N—H+Cl− and C—HO interactions, and a putative C—HF interaction. The piperidine ring assumes a chair conformation, with the substituted benzisoxazole ring in an equatorial position.
organic compounds
The title compound, C22H21ClN4O, is used as an intermediate for the synthesis of biologically active compounds. Geometric parameters are in the usual ranges. The packing is stabilized by O—HN hydrogen bonding.
organic compounds
The title compound (3-carboxypiperidinium chloride), C6H12NO2+·Cl−, is the hydrochloride of nipecotic acid and is used as a drug intermediate and in the synthesis of γ-aminobutyric acid (GABA) uptake inhibitors. The geometric parameters are in the normal ranges. The crystal packing is stabilized by O—HCl and N—HCl hydrogen bonds.
organic compounds
The title compound, C33H25BrN4, belongs to the class of substituted tetrazoles. This type of compound is an important starting material for the synthesis of pharmaceutically active materials.
organic compounds
The title compound, C14H16N2, adopts a trans-planar conformation. However, the molecule, which possesses Ci point group symmetry, crystallizes in the non-centrosymmetric space group P212121. In the crystal structure, the molecular symmetry is only approximately retained. The crystal packing is predominantly stabilized by N—HN hydrogen bonds. Weak C—Hπ interactions also contribute to the stability.
organic compounds
Open access
The structure of the title compound, C6H13ClNO+·Cl-, comprises a cation with the morpholine ring in the chair conformation, and a single hydrogen-bonding association between the morpholinium NH group and the Cl- anion.
organic compounds
The title compound, C14H12O2, is used as an intermediate for the synthesis of various biologically active and pharmaceutical compounds. Bond lengths and angles adopt usual values. The dihedral angles between the two aromatic rings [53.39 (3)°] and between the carboxyl group and adjacent ring [42.37 (10)°] lie in the expected ranges. The crystal structure is characterized by centrosymmetric hydrogen-bonded dimers.
organic compounds
The title compound, C22H20ClN3O, (I), is used as an intermediate for the synthesis of the antihypertensive drug losartan. Bond lengths and angles are unexceptional. The crystal packing is stabilized by one C—HO and one C—HN contact. It is noteworthy that (I) is isomorphous with a closely related compound which differs in having a but-2-enyl chain instead of a butyl chain on the imidazole ring.
organic compounds
Open access
The structure of the title compound, C16H14N2O2, contains a seven-membered ring that adopts a boat conformation, and the overall molecular shape is that of a butterfly. In the packing, the molecules form a convoluted hydrogen-bonded polymer via a typical R22(8) graph-set dimer, between carboxamide groups, and an R22(16) graph-set dimer formed through an interaction between the second carboxamide NH group and an adjacent methoxy O atom (in each molecule). The dihedral angle between the benzene rings is 56.09 (5)°.
organic compounds
In the title compound, 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-thione, C15H11ClN2S, the central seven-membered diazepinethione ring adopts a boat conformation. The dihedral angle between the planes of the aromatic rings is 63.7 (1)°. The crystal packing is determined by strong N—HN hydrogen bonds, generating a one-dimensional chain along [001].